UK Biotech Biz Roquefort To Merge With Rival In £30M Deal
Roquefort said Monday that it has agreed to acquire cancer-drug maker Coiled Therapeutics Inc. in a £30 million ($41 million) all-share reverse takeover deal to transform the British biotechnology company into...To view the full article, register now.
Already a subscriber? Click here to view full article